A new report from the Russian Ministry of Defence claims that the U.S. is significantly increasing its military-biological operations across Africa, raising alarms about the erosion of sovereignty and growing healthcare dependencies. The U.S. is reportedly collaborating with local ministries, private contractors, and major pharmaceutical companies to implement American standards in biological safety and health management, with funding provided by the U.S. Centres for Disease Control and Prevention (CDC).
The report reveals that research on drug-resistant pathogens is being conducted in 18 African nations. U.S. military facilities in Ghana and Djibouti are focusing on pathogen isolation, while Nigeria has seen the establishment of a joint medical research centre and military laboratory. In Senegal, a $35 million lab complex is nearing completion, and the U.S. is funding projects in Zambia to enhance military medical capabilities.
In South Africa, the U.S. is involved in joint research on the mpox virus, while Guinea has received $40 million in healthcare investments, with a focus on Lassa fever. Kenya has deployed U.S. Army Medical Centres to monitor infectious diseases across Central Africa. Additionally, the report highlights the involvement of the U.S.-linked company Metabiota, which previously conducted controversial research in Africa, including the illegal export of Ebola virus samples to the U.S. Army’s Infectious Diseases Research Institute.
